United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Thu, Dec 15 2016


Lonza to buy U.S. drug capsule maker Capsugel from KKR for $5.5 billion

Swiss pharmaceutical supplier Lonza Group AG on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP for $5.5 billion in cash to broaden its product range.

Exclusive: Lonza says in talks to buy Capsugel; deal could top $5 billion - sources

Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.

BRIEF-Lonza Group expects to reach 2018 guidance year early

* Says strong momentum in q3 gives us confidence to specify that core ebit is on track to cross 15% growth line for full-year 2016

BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing

* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing

Lonza buys InterHealth in health push

ZURICH Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.

Lonza buys InterHealth in health push

* Lonza to spend up to $300 million on health-supplements target

Select another date: